Dynamics of SOX2 and CDX2 Expression in Barrett’s Mucosa

Figure 3

CDX2 expression in single-patient subsequent biopsies. (a) CDX2 negative immunostaining in the index biopsy with CLES, (b) a subsequent biopsy (4 years later) with CLES showing focal CDX2 positivity, and (c) CDX2 expression in BE (9 years after index biopsy) with extensive CDX2 positivity.

(a)

(b)

(c)